September 12, 2022

0
:
days
00
hours
:
00
minutes
:
00
seconds
Gold Sponsor
Mobile Tech and DPHARM

Join Viz.ai at Mobile Tech in Clinical Trials and DPHARM

Viz.ai is at Mobile Tech in Clinical Trials and DPHARM

Thanks for joining Viz.ai at Mobile Tech Clinical Trials and DPHARM

Sep 12
-
14
Sep 14, 2022
,
2022
The Westin Copley Place
Boston, Massachusetts

Live events at the conference

Dr.
Hassan Kadim
,
Dir. Head of Clinical Trial Business Capabilities, Global Development Operations | BMS
at
at
at
Dr.
Hung Nguyen, PhD
,
Assoc. Director, Digital Health | Janssen Pharmaceuticals
at
at
at
Dr.
Jayme Strauss
,
RN, MSN, MBA, SCRN
Chief Clinical Officer
at
Viz.ai
at
at
Dr.
Isaac Rodriguez-Chavez, PhD
,
SVP, Scientific & Clinical Affairs, Head, Decentralized Clinical Trials & Digital Medicine Strategy | ICON
at
at
at
Dr.
Rinol Alaj
,
Senior Director, Head of Clinical Outcomes Assessment & Patient Innovation, Regeneron
at
at
at
Discussion and Q&A

Mobilizing Clinical Trials Panel Discussion

September 12, 2022
at
11:30 am
The Westin Copley Place, America South, 4th Floor

Related Resources

No items found.

Neuro Care Coordination Powered by AI

Viz.ai Neuro Platform: Viz LVO, Viz ANEURYSM, Viz ICH

Viz.ai uses artificial intelligence to detect suspected disease and notify care teams with high fidelity mobile image viewing, patient information and secure chat to quickly coordinate care and make treatment decisions.

The comprehensive neurovascular AI platform has been shown to save time and improve patient outcomes and is used in over 1,000 hospitals in the US and EMEA.

Request a meetingRequest a meeting

One platform, whenever you need it.

Viz.ai empowers multidisciplinary care teams to coordinate care across mobile, desktop, and within the radiology workflow.

Viz.ai platform across mobile, desktop, and the radiology workflow.

AI-powered pulmonary embolism care coordination on the proven platform

Viz.ai uses artificial intelligence to detect suspected disease and notify care teams with high fidelity mobile image viewing, patient information and secure chat to quickly coordinate care and make treatment decisions.

Viz.ai is approved for a variety of indications, including pulmonary embolism, aortic dissection, large-vessel occlusion, and more.

The Proven AI Powered Care Coordination Platform

Viz.ai platform, showing mobile devices and desktop

Viz.ai uses artificial intelligence to detect suspected disease and notify care teams with high fidelity mobile image viewing, patient information and secure chat to quickly coordinate care and make treatment decisions.

The comprehensive neurovascular AI platform has been shown to save time and improve patient out

Request a meetingRequest a meeting
Learn how AI-powered care coordination expedites trial enrollment

Viz RECRUIT enables real-time patient recruitment within the health system.

Viz RECRUIT’s ability to embed clinical research into the care continuum results in a ~3x faster enrollment rate1. This translates into timely completion of clinical trials and accelerates the path to market for life-saving therapies.

1 Jankowitz B. et al 2021,SNIS-E-022

Demonstrated Time Savings leads to Improved Outcomes

Save Time1
Arrow icon
73%
Faster Treatment Decision
Reduce Length of Stay2
Arrow icon
2.5
Day Reduction in Hospital LOS
Improve Outcomes3
Arrow icon
25%
Patient Improvement at 90 Days
  1. Elijovich L, DornbosIII D, Nickele C, et al. J NeuroIntervent Surg Epub ahead of print. doi:10.1136/ neurintsurg-2021-017714
  2. Hassan, A, et al. Interventional Neuroradiology, 2020.
  3. 'Real-World Experience with Artificial Intelligence-Based Triage in Transferred Large Vessel Occlusion Stroke Patients, Morey et al, Cerebrovasc Dis 2021;50:450-455, DOI: 10.1159/000515320
+